These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP): basic concept of vaccination and prospect of clinical application. Homma JY; Tanimoto H Kitasato Arch Exp Med; 1988 Sep; 61(2-3):81-93. PubMed ID: 3145353 [No Abstract] [Full Text] [Related]
3. Antibody titers in serum of diffuse panbronchiolitis patients administered a multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase and exotoxin A and a common protective antigen (OEP). Yamamoto M; Kubota Y; Matsuura M; Homma JY Kitasato Arch Exp Med; 1988 Sep; 61(2-3):127-35. PubMed ID: 3145352 [No Abstract] [Full Text] [Related]
4. [Antibody titers in the serum of patients vaccinated with the multicomponent vaccine consisting of toxoids of protease, elastase and a common protective antigen (OEP)]. Yamamoto M; Kubota Y; Matsuura M; Homma JY Kansenshogaku Zasshi; 1986 Nov; 60(11):1178-83. PubMed ID: 3102639 [No Abstract] [Full Text] [Related]
5. [Protective properties of anatoxin obtained from a homogeneous preparation of Pseudomonas aeruginosa exotoxin A]. Brodinova NS; Vovk VA; Aleksandrov AD; Moroz AF Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):3-8. PubMed ID: 2508376 [TBL] [Abstract][Full Text] [Related]
6. A multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase, exotoxin A and a common protective antigen (OEP). Application in patients with diffuse panbronchiolitis. Homma JY; Tanimoto H Antibiot Chemother (1971); 1987; 39():215-21. PubMed ID: 3118783 [No Abstract] [Full Text] [Related]
7. Efficacies of alkaline protease, elastase and exotoxin A toxoid vaccines against gut-derived Pseudomonas aeruginosa sepsis in mice. Matsumoto T; Tateda K; Furuya N; Miyazaki S; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K J Med Microbiol; 1998 Apr; 47(4):303-8. PubMed ID: 9568995 [TBL] [Abstract][Full Text] [Related]
8. Toxoids of Pseudomonas aeruginosa exotoxin-A: photoaffinity inactivation of purified toxin and purified toxin derivatives. Callahan LT; Martinez D; Marburg S; Tolman RL; Galloway DR Infect Immun; 1984 Mar; 43(3):1019-26. PubMed ID: 6321348 [TBL] [Abstract][Full Text] [Related]
9. A polyvalent Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. Cryz SJ; Fürer E; Sadoff JC; Germanier R Antibiot Chemother (1971); 1987; 39():249-55. PubMed ID: 3118786 [No Abstract] [Full Text] [Related]
10. Is Pseudomonas aeruginosa exotoxin A a good carrier protein for conjugate vaccines? Pier GB Hum Vaccin; 2007; 3(2):39-40; author reply 41. PubMed ID: 17268204 [No Abstract] [Full Text] [Related]
11. Pseudomonas aeruginosa exotoxin A antibodies in rapidly deteriorating chronic leg ulcers. Danielsen L; Westh H; Balselv E; Rosdahl VT; Döring G Lancet; 1996 Jan; 347(8996):265. PubMed ID: 8551911 [No Abstract] [Full Text] [Related]
12. [Protective polysaccharide-protein artificial antigens from O-specific polysaccharides of Pseudomonas aeruginosa and its exotoxin A]. Dmitriev BA; Kul'shin VA; Antsiferova NG; Vovk VA; Moroz AF Dokl Akad Nauk SSSR; 1988; 298(5):1277-80. PubMed ID: 2454182 [No Abstract] [Full Text] [Related]
13. Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization. Pollack M; Prescott RK J Infect Dis; 1982 May; 145(5):688-98. PubMed ID: 6804576 [TBL] [Abstract][Full Text] [Related]
14. Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids. Pavlovskis OR; Edman DC; Leppla SH; Wretlind B; Lewis LR; Martin KE Infect Immun; 1981 May; 32(2):681-9. PubMed ID: 6788700 [TBL] [Abstract][Full Text] [Related]
15. Toxoids of Pseudomonas aeruginosa toxin A: production by chemical and genetic means. Cryz SJ; Iglewski BH Rev Infect Dis; 1983; 5 Suppl 5():S992-7. PubMed ID: 6419321 [TBL] [Abstract][Full Text] [Related]
16. [Isolation of different variants of Pseudomonas aeruginosa anatoxin and their characteristics]. Brodinova NS; Levdikova GA; Moroz AF Zh Mikrobiol Epidemiol Immunobiol; 1987 Mar; (3):6-12. PubMed ID: 2438865 [TBL] [Abstract][Full Text] [Related]
17. [Prevelance of antibodies ot OEP, exotoxin A, and exoenzymes of Pseudomonas aeruginosa in man (author's transl)]. Shinozaki T; Fujii R; Sanai Y; Homma JY Kansenshogaku Zasshi; 1981 Jan; 55(1):32-40. PubMed ID: 6788869 [No Abstract] [Full Text] [Related]
18. Use of Pseudomonas aeruginosa toxin A in the construction of conjugate vaccines and immunotoxins. Cryz SJ; Fürer E; Sadoff JC; Germanier R; Pastan I; Willingham MC; FitzGerald DJ Rev Infect Dis; 1987; 9 Suppl 5():S644-9. PubMed ID: 3120274 [TBL] [Abstract][Full Text] [Related]
19. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients. Jagger KS; Robinson DL; Franz MN; Warren RL J Clin Microbiol; 1982 Jun; 15(6):1054-8. PubMed ID: 6809785 [TBL] [Abstract][Full Text] [Related]
20. Preparation of recombinant atoxic form of exotoxin A from Pseudomonas aeruginosa. Kaloshin AA; Isakov MA; Mikhailova NA; Vertiev JV Bull Exp Biol Med; 2013 Jan; 154(3):346-50. PubMed ID: 23484197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]